Skip to main content

Mergen to Manufacture Others Microarrays for Resale

NEW YORK, Jan. 24 (GenomeWeb News) - Mergen plans to manufacture microarrays for resale by other companies, the San Leandro, Calif.-based company said today.

 

Under a new service of original equipment manufacturing, Mergen will make custom DNA arrays for gene-expression analysis that other companies can resell under their own trademark or co-branded with Mergen. Mergen will also continue to sell its own pre-printed ExpressChip arrays.

 

Last week, the company said it purchased a license from Oxford Gene Technology that allows it to manufacture and sell microarrays for gene-expression studies.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.